Vilget-M Tablets 50Mg/850Mg (1 Box = 28 Tablets)

The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased...

PKR 220.00

PKR 209.00

You save: PKR 11.00

Quantity:

SKU: VILGET_M_50_850MG_TAB_28S_NV

Category: Personal care

The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.

Purpose

Diabetes

Ingredients

Vildagliptin + Metformin HCl

Warnings

In diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.
Use of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin is advised to be discontinued and if acute pancreatitis is confirmed, vildagliptin is advised to not be restarted. Caution is advised to be exercised in patients with a history of acute pancreatitis.
Treatment with metformin is advised to be discontinued 48 hours before elective surgery with general anesthesia and is advised to not usually be resumed earlier than 48 hours afterwards.

Side Effects

Hypoglycemia, tremor, headache, dizziness & nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis & asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea & flatulence.